IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -22.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -22.12% | |||
| Cost of Revenue | -85.96% | -33.72% | |||
| Gross Profit | -133.33% | 33.33% | |||
| SG&A Expenses | -24.15% | -23.62% | |||
| Depreciation & Amortization | -5.71% | 1.45% | |||
| Other Operating Expenses | -43.25% | 10.13% | |||
| Total Operating Expenses | -36.63% | -2.86% | |||
| Operating Income | 34.94% | 2.22% | |||
| Income Before Tax | 53.05% | 48.99% | |||
| Income Tax Expenses | -- | -2,250.00% | |||
| Earnings from Continuing Operations | 52.08% | 50.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 52.08% | 50.05% | |||
| EBIT | 34.94% | 2.22% | |||
| EBITDA | 36.35% | 5.16% | |||
| EPS Basic | 65.95% | 86.09% | |||
| Normalized Basic EPS | 66.74% | -240.00% | |||
| EPS Diluted | 66.29% | 85.95% | |||
| Normalized Diluted EPS | 66.74% | -240.00% | |||
| Average Basic Shares Outstanding | 40.91% | 259.37% | |||
| Average Diluted Shares Outstanding | 40.91% | 259.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||